FRANKS: I wanted to move to medicinal cannabis and I get that there is an overlap here with the TGA and the Office of Drug Control, but my questions on notice—because I am not expecting you to have them in your notes, although I will be thrilled if you do—just how many medical practitioners have been able to prescribe, whether they are authorised prescribers, or been able to prescribe medicinal cannabis products; what the categories of health conditions have been for that; how many patients in South Australia have been able to access medicinal cannabis; and if there is any breakdown available into things like whether they have been able to access that because of palliative care versus other conditions, if that could be provided?

................... 10 Reporting required under the Carers’ Recognition Act 2005 ............................................ 11 Section C: Reporting of public complaints as requested by the Ombudsman. 12 Summary of complaints by subject .................................................................................. 12 Complaint outcomes ........................................................................................................ 12 Appendix: Audited financial statements 2017-18 ................................................ 13 2017-18 ANNUAL REPORT for the Controlled Substances Advisory Council 4 | P a g e Section A: Reporting required under the Public Sector Act 2009, the Public Sector Regulations 2010 and the Public Finance and Audit Act 1987 Agency purpose or role To ensure the Controlled Substances legislation promotes and protects public health and safety by minimizing:  Unintentional poisoning  Deliberate poisoning  Medicinal

The latter would result in criminal prosecution. 2.3 The then Minister for Health highlighted this divide in his second reading speech: The expiation fees will apply to the possession and use of small amounts of cannabis and cannabis resin, the cultivation of cannabis for non-commercial purposes and the possession of implements which are connected with the use of cannabis or cannabis resin.

................... 8 Reporting required under the Carers’ Recognition Act 2005 .............................................. 9 Section C: Reporting of public complaints as requested by the Ombudsman. 10 Summary of complaints by subject .................................................................................. 10 Complaint outcomes ........................................................................................................ 10 Appendix: Audited financial statements 2016-17 ................................................ 11 2016-17 ANNUAL REPORT for the Controlled Substances Advisory Council 4 | P a g e Section A: Reporting required under the Public Sector Act 2009, the Public Sector Regulations 2010 and the Public Finance and Audit Act 1987 Agency purpose or role To ensure the Controlled Substances legislation promotes and protects public health and safety by minimizing:  Unintentional poisoning  Deliberate poisoning  Medicinal

Ms ANTCLIFF: We haven't had any discussions on this particular case and we are, as we said at the beginning, working through what oversight measures are agreeable between the Tourism Commission and DTTI. 6831 The CHAIRPERSON: A different topic—and I think we will come back to that, but time is getting on: is the Office of Industrial Hemp and Medicinal Cannabis based in DTTI?

I am interested in the new Office of Industrial Hemp and Medicinal Cannabis.

General - Taking of Cannabis Samples

FRANKS: The first topic is on the Office of Industrial Hemp and Medicinal Cannabis.

To assist the treatment of epilepsy in children, a pilot will be established to trial the use of medicinal cannabis. 28 Compassionate access to the medicine will be provided for children who are not responding to other treatment options.

The latter would result in criminal prosecution. 2.3 The then Minister for Health highlighted this divide in his second reading speech: The expiation fees will apply to the possession and use of small amounts of cannabis and cannabis resin, the cultivation of cannabis for non-commercial purposes and the possession of implements which are connected with the use of cannabis or cannabis resin.